Cohen Jacob D.insider trades
In SEC Form 4 filings, Cohen Jacob D. is listed as Chief Executive Officer of Mangoceuticals, Inc. (MGRX). Cohen Jacob D. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 6.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| MGRXMangoceuticals, Inc. | Chief Executive Officer | 6 | Oct 6 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-06
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| MGRXMangoceuticals, Inc. | Aug 11 | Oct 6 | G | 2,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| MGRXMangoceuticals, Inc. | Aug 11 | Oct 6 | G | 2,000,000 | $0.00 | $0 | 3,305,000 | No | Form 4 |
| MGRXMangoceuticals, Inc. | Jul 28 | Oct 6 | A | 2,000,000 | $0.00 | $0 | 2,000,000 | No | Form 4 |
| MGRXMangoceuticals, Inc. | Dec 19, 2025 | Oct 6 | J · derivative | 56,023 | $1.79 | $100,001 | not reported | No | Form 4 |
| MGRXMangoceuticals, Inc. | Sep 30, 2025 | Oct 6 | G | 500,000 | $0.00 | $0 | not reported | No | Form 4 |
| MGRXMangoceuticals, Inc. | Sep 30, 2025 | Oct 6 | G | 500,000 | $0.00 | $0 | 1,305,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.